Structural insights into the role of the ACTH receptor cysteine residues on receptor function

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 293, Issue 3, 2007, Pages

  Yang, Yingkui ^a   Chen, Min ^b   Kesterson Jr , Robert Allen ^c   Harmon, Carroll M ^a  

^a Kentucky   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Familial glucocorticoid deficiency; G protein coupled receptor; Melanocortin 2 receptor; Melanocortin receptor

Indexed keywords

CORTICOTROPIN RECEPTOR; CYSTEINE; SERINE;

ARTICLE; BINDING AFFINITY; DISULFIDE BOND; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BINDING;

ADRENOCORTICOTROPIC HORMONE; AMINO ACID SEQUENCE; CELL LINE; CYCLIC AMP; CYSTEINE; DISULFIDES; DITHIOTHREITOL; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROTEIN CONFORMATION; RECEPTOR, MELANOCORTIN, TYPE 2; SULFHYDRYL REAGENTS; TRANSFECTION;

EID: 34548425115     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00240.2007     Document Type: Article

References (31)

1. Chai BX, Pogozheva ID, Lai YM, Li JY, Neubig RR, Mosberg HI, Gantz I. Receptor-antagonist interactions in the complexes of agouti and agouti-related protein with human melanocortin 1 and 4 receptors. Biochemistry 44: 3418-3431, 2005.
2. Clark AJ, Cammas FM. The ACTH receptor. Baillieres Clin Endocrinol Metab 10: 29-47, 1996.
3. Cook JV, Eidne KA. An intramolecular disulfide bond between conserved extracellular cysteines in the gonadotropin-releasing hormone receptor is essential for binding and activation. Endocrinology 138: 2800-2806, 1997.
4. Davidson FF, Loewen PC, Khorana HG. Structure and function in rhodopsin: replacement by alanine of cysteine residues 110 and 187, components of a conserved disulfide bond in rhodopsin, affects the light-activated metarhodopsin II state. Proc Natl Acad Sci USA 91: 4029-4033, 1994.
5. DeBlasi A, O'Reilly K, Motulsky HJ. Calculating receptor number from binding experiments using same compound as radioligand and competitor. Trends Pharmacol Sci 10: 227-229, 1989.
6. Dohlman HG, Caron MG, DeBlasi A, Frielle T, Lefkowitz RJ. Role of extracellular disulfide-bonded cysteines in the ligand binding function of the beta 2-adrenergic receptor. Biochemistry 29: 2335-2342, 1990.
7. Eason MG, Jacinto MT, Theiss CT, Liggett SB. The palmitoylated cysteine of the cytoplasmic tail of alpha 2A-adrenergic receptors confers subtype-specific agonist-promoted downregulation. Proc Natl Acad Sci USA 91: 11178-11182, 1994.
8. Frandberg PA, Doufexis M, Kapas S, Chhajlani V. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist. Biochem Biophys Res Commun 281: 851-857, 2001.
9. Gantz I, Konda Y, Tashiro T, Shimoto Y, Miwa H, Munzert G, Watson SJ, DelValle J, Yamada T. Molecular cloning of a novel melanocortin receptor. J Biol Chem 268: 8246-8250, 1993.
10. Gantz I, Miwa H, Konda Y, Shimoto Y, Tashiro T, Watson SJ, DelValle J, Yamada T. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J Biol Chem 268: 15174-15179, 1993.
11. Gantz I, Shimoto Y, Konda Y, Miwa H, Dickinson CJ, Yamada T. Molecular cloning, expression, and characterization of a fifth melanocortin receptor. Biochem Biophys Res Commun 200: 1214-1220, 1994.
12. Haskell-Luevano C, Cone RD, Monck EK, Wan YP. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants. Biochemistry 40: 6164-6179, 2001.
13. Imamine H, Mizuno H, Sugiyama Y, Ohro Y, Sugiura T, Togari H. Possible relationship between elevated plasma ACTH and tall stature in familial glucocorticoid deficiency. Tohoku J Exp Med 205: 123-131, 2005.
14. Karlin A, Akabas MH, Czajkowski C, Kaufmann C, Stauffer D, Xu M. Structures involved in binding, gating, and conduction in nicotinic acetylcholine receptors. Renal Physiol Biochem 17: 184-186, 1994.
15. Kobilka BK, Kobilka TS, Daniel K, Regan JW, Caron MG, Lefkowitz RJ. Chimeric alpha 2-,beta 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. Science 240: 1310-1316, 1988.
16. Kubo M, Shimizu C, Kijima H, Nagai S, Koike T. Alternate promoter and 5′-untranslated exon usage of the mouse adrenocorticotropin receptor gene in adipose tissue. Endocr J 51: 25-30, 2004.
17. Lisenbee CS, Dong M, Miller LJ. Paired cysteine mutagenesis to establish the pattern of disulfide bonds in the functional intact secretin receptor. J Biol Chem 280: 12330-12338, 2005.
18. Matsuura H, Shiohara M, Yamano M, Kurata K, Arai F, Koike K. Novel compound heterozygous mutation of the MC2R gene in a patient with familial glucocorticoid deficiency. J Pediatr Endocrinol Metab 19: 1167-1170, 2006.
19. Metherell LA, Chapple JP, Cooray S, David A, Becker C, Ruschendorf F, Naville D, Begeot M, Khoo B, Nurnberg P, Huebner A, Cheetham ME, Clark AJ. Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2. Nat Genet 37: 166-170, 2005.
20. Mountjoy KG, Robbins LS, Mortrud MT, Cone RD. The cloning of a family of genes that encode the melanocortin receptors. Science 257: 1248-1251, 1992.
21. Narita M, Suzuki M, Niikura K, Nakamura A, Miyatake M, Yajima Y, Suzuki T. mu-opioid receptor internalization-dependent and -independent mechanisms of the development of tolerance to mu-opioid receptor agonists: comparison between etorphine and morphine. Neuroscience 138: 609-619, 2006.
22. Probst WC, Snyder LA, Schuster DI, Brosius J, Sealfon SC. Sequence alignment of the G-protein coupled receptor superfamily. DNA Cell Biol 11: 1-20, 1992.
23. Raikhinstein M, Zohar M, Hanukoglu I. cDNA cloning and sequence analysis of the bovine adrenocorticotropic hormone (ACTH) receptor. Biochim Biophys Acta 1220: 329-332, 1994.
24. Stauffer DA, Karlin A. Electrostatic potential of the acetylcholine binding sites in the nicotinic receptor probed by reactions of binding-site cysteines with charged methanethiosulfonates. Biochemistry 33: 6840-6849, 1994.
25. Takeuchi S, Kudo T, Takahashi S. Molecular cloning of the chicken melanocortin 2 (ACTH)-receptor gene. Biochim Biophys Acta 1403: 102-108, 1998.
26. Tarnow P, Schoneberg T, Krude H, Gruters A, Biebermann H. Mutationally induced disulfide bond formation within the third extracellular loop causes melanocortin 4 receptor inactivation in patients with obesity. J Biol Chem 278: 48666-48673, 2003.
27. Ulloa-Aguirre A, Uribe A, Zarinan T, Bustos-Jaimes I, Perez-Solis MA, Dias JA. Role of the intracellular domains of the human FSH receptor in G(alphaS) protein coupling and receptor expression. Mol Cell Endocrinol 260-262: 153-162, 2007.
28. VanLeeuwen D, Steffey ME, Donahue C, Ho G, MacKenzie RG. Cell surface expression of the melanocortin-4 receptor is dependent on a C-terminal di-isoleucine sequence at codons 316/317. J Biol Chem 278: 15935-15940, 2003.
29. Vazquez P, Roncero I, Blazquez E, Alvarez E. Substitution of the cysteine 438 residue in the cytoplasmic tail of the glucagon-like peptide-1 receptor alters signal transduction activity. J Endocrinol 185: 35-44, 2005.
30. Yang Y, Dickinson C, Haskell-Luevano C, Gantz I. Molecular basis for the interaction of [Nle4,D-Phe7]melanocyte stimulating hormone with the human melanocortin-1 receptor. J Biol Chem 272: 23000-23010, 1997.
31. Yang YK, Fong TM, Dickinson CJ, Mao C, Li JY, Tota MR, Mosley R, Van Der Ploeg LH, Gantz I. Molecular determinants of ligand binding to the human melanocortin-4 receptor. Biochemistry 39: 14900-14911, 2000.